Glaxo Smithkline reports N16.45bn as turnover in Q3 2021

Glaxo Smithkline Consumer Nigeria in its published third quarter report for the period ended 30 September 2020 reported a turnover of N16.452 billion. This is marginally up by 0.03% compared N16.447 billion turnover reported the previous year.

The company declared a profit after tax of N122.699 million for the nine months period, down by 71.75% from N434.321 million reported the previous year.

Earnings per share for the period under review stands at 10 kobo, down by 71.75% from the EPS of 36 kobo achieved the previous year.

At the share price of N7, the PE ratio of Glaxo Smithkline stands at 68.23x with earnings yield of 1.47%.

Leave a Reply

Your email address will not be published. Required fields are marked *